InterTabac 2025 Highlights Europe’s Vaping Dilemma: Tighter Regulation, Constrained Innovation

Sep.19
InterTabac 2025 Highlights Europe’s Vaping Dilemma: Tighter Regulation, Constrained Innovation
According to 2Firsts’ on-site observations, the vaping halls at InterTabac 2025 have visibly cooled: fewer exhibitors, a weaker presence from major brands, and scarce stage activations; new product momentum is weak and homogenization has intensified. Tightening regulation and policy uncertainty are squeezing innovation, pushing companies to replicate proven models—overall, a “cautious showcase.”

InterTabac 2025 is underway in Dortmund, Germany. 2Firsts’ on-site reporting finds that this year’s vaping halls feel noticeably different from last year.

 

First, in terms of exhibitors, the number of vaping brands has fallen, and the presence of major players is less pronounced than in 2024. Overall foot traffic is similar, but exhibitors’ enthusiasm is clearly lower. From booth size to finishing details, the change is palpable. Last year many stands featured dancers, DJs, and other performances; such spectacles are rarely seen this year.

 

Second, at the product level, genuinely new launches are scarce. Homogenization is striking: booths are dominated by pod-based and open-system devices with little real novelty. Many products use transparent tanks and “2+10” or “0+10” bundle formats, but differences among offerings are limited.

 

Conversations with multiple exhibitors suggest that, beyond a general slowdown in European innovation, regulatory pressure is a key driver. Germany’s rules are stringent; during the show, plainclothes customs officers were reportedly checking on site whether products carried tax stamps. A tax stamp implies compliance with the TPD (EU Tobacco Products Directive), which tightly restricts product formats and specifications—leaving manufacturers little room to design and innovate.

 

In fact, Europe’s broader novel-nicotine market is in a period of regulatory uncertainty. Without clear policy signals, companies are reluctant to commit to R&D and instead prefer to “replicate” existing winners.

 

Overall, this year’s Dortmund show feels more like a “cautious showcase.” Under regulatory pressure and market uncertainty, the industry’s appetite for innovation has clearly weakened.

 


For more on-the-ground coverage, visit the 2Firsts InterTabac Special Section.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Customs Seizes Over 265K Oral Nicotine Pouches; ‘ZYN’ and Unbranded Products Flagged for IP Violations
China Customs Seizes Over 265K Oral Nicotine Pouches; ‘ZYN’ and Unbranded Products Flagged for IP Violations
China Customs seized 265,140 oral nicotine pouches, including “ZYN”-branded and unbranded products, over suspected IP infringement and breaches of tobacco export rules.
Oct.10 by 2FIRSTS.ai
Ispire Releases 2025 Financial Results: Revenue of $127.5 Million, Net Loss Widens to $39.2 Million
Ispire Releases 2025 Financial Results: Revenue of $127.5 Million, Net Loss Widens to $39.2 Million
Ispire Technology Inc. (NASDAQ: ISPR) announced its financial results for the fiscal year ending June 30, 2025, on September 16, 2025. The report showed that the company's operating revenue was $127.5 million, down from $151.9 million in the previous fiscal year. Gross profit decreased from $29.8 million to $22.6 million, with gross profit margin falling from 19.6% to 17.8%. Net loss widened from $14.8 million to $39.2 million.
Sep.17 by 2FIRSTS.ai
Reuters: FDA relaxes requirements for nicotine pouch pilot program, cancels special research on some products
Reuters: FDA relaxes requirements for nicotine pouch pilot program, cancels special research on some products
US FDA meeting minutes: Under Trump, a new pilot eases nicotine pouch rules—cuts product-specific research (uses generic data), shortens reviews, boosts communication. It’s the FDA’s first clear softer stance on smoking alternatives. The pilot may benefit Philip Morris (Zyn), Altria (On!), BAT (Velo) but sparks debate: FDA says pouches are low-risk (no youth surge), while ex-officials/academics cite missing research (hurts health checks, risks hidden youth use). Firms note costly research remain
Sep.19 by 2FIRSTS.ai
BAT leaders caution that EU tax hikes may recreate Australia’s ‘black market expansion’ scenario.
BAT leaders caution that EU tax hikes may recreate Australia’s ‘black market expansion’ scenario.
BAT execs warn that steep EU tax hikes on cigarettes and alternatives could spur an Australia-style surge in illicit tobacco, arguing smugglers profit even if 24 of 25 containers are seized; the European Commission disputes this view.
Oct.14
Bangladesh Approves Philip Morris Factory for Nicotine Pouches, Sparks Controversy: Regulator Says It’s “Completely Legal”
Bangladesh Approves Philip Morris Factory for Nicotine Pouches, Sparks Controversy: Regulator Says It’s “Completely Legal”
Philip Morris Bangladesh Limited (PMBL) has received approval to invest USD 5.82 million in a nicotine pouch factory in Narayanganj. Regulators say the project is legal under existing laws, while health groups argue it breaches a 2016 Supreme Court order and poses youth addiction risks.
Nov.07 by 2FIRSTS.ai
PMI Urges South Africa to Differentiate Smoke-Free Products from Cigarettes
PMI Urges South Africa to Differentiate Smoke-Free Products from Cigarettes
South Africa is drafting new tobacco legislation aimed at reducing smoking-related deaths and promoting harm reduction.PMI said smoke-free products such as nicotine pouches and heated devices could play a critical role in reducing harm. Patrik Hildingsson, PMI’s director for oral products communications, said South Africa is developing a new regulatory framework to recognise and regulate smoke-free products, calling it a “big change” for the industry.
Oct.22 by 2FIRSTS.ai